»

DrugPatentWatch

DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,400 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices.

Patent: 7,148,211

Summary for Patent: 7,148,211

Title:Formulation for lipophilic agents
Abstract:The invention relates to pharmaceutical formulations of lipophilic therapeutic agents in which such agents are solubilized in largely aqueous vehicles, and processes for preparing and using the same.
Inventor(s): Mazess; Richard B. (Madison, WI), Driscoll; Jeffrey W. (Middleton, WI), Goldensoph; Creighton Reed (DeForest, WI), LeVan; Leon W. (Oregon, WI)
Assignee: Genzyme Corporation (Cambridge, MA)
Application Number:10/247,765
Patent Claim Types:
see list of patent claims
Formulation; Compound; Use;
Patent PDF download available with subscription

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Product Substance Delist_Flag Patent Expiration Patented / Exclusive Use
Genzyme Corp
HECTOROL
doxercalciferol
INJECTABLE; INJECTION021027Apr 6, 2000RXNo7,148,211YY<disabled>
Genzyme Corp
HECTOROL
doxercalciferol
INJECTABLE; INJECTION021027Apr 6, 2000RXYes7,148,211YY<disabled>
The preview shows a limited data set. Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

Patent activity for: 7,148,211

Inter partes reexamination
Filing: 7,148,211, Reexam. C.N.: 95/001,245, Requested Date: Oct. 13, 2009, Cl.: 514/168, Title: FORMULATION FOR LIPOPHILIC AGENTS, Inventor: Richard B. Mazess et al., Owners of Record: Genzyme Corporation, Cambridge, MA, Attorney or Agent: Michael Best & Friedrich, LLP., Madison, WI, Ex. Gp.: 3991, Requester: Third Party Requester: Cobrek Pharmaceuticals, Inc., (Att'y Is: Robert S. Silver, Caesar Rivise Bernstein Cohen And Pokotilow LTD., Philadelphia, PA), Real Party in Interest: Same As Third Party Requester
Inter partes reexamination
Filing: 7,148,211, Reexam. C.N.: 95/001,245, Requested Date: Oct. 13, 2009, Cl.: 514/168, Title: FORMULATION FOR LIPOPHILIC AGENTS, Inventor: Richard B. Mazess et al., Owners of Record: Genzyme Corporation, Cambridge, MA, Attorney or Agent: Michael Best & Friedrich, LLP., Madison, WI, Ex. Gp.: 3991, Requester: Third Party Requester: Cobrek Pharmaceuticals, Inc., (Att'y Is: Robert S. Silver, Caesar Rivise Bernstein Cohen And Pokotilow LTD., Philadelphia, PA), Real Party in Interest: Same As Third Party Requester

International Patent Family for Patent: 7,148,211

Country Document Number Publication Date
Australia2003267131Apr 08, 2004
Brazil0314354Jul 19, 2005
Canada2498331Apr 01, 2004
China100349573Nov 21, 2007
The preview shows a limited data set. Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.


« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Sign up for a free trial

No commitment, no credit card required
First name
Last name
Email address

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639


`abc